Bhanvi Satija and Reuters 13 hours in the past FILE – An indication for Eli Lilly & Co. stands outdoors their company headquarters in Indianapolis on April 26, 2017. Zepbound, a brand new model of the corporate’s common diabetes therapy Mounjaro will be bought as a weight-loss drug, U.S. regulators introduced Wednesday, Nov. 8, 2023....
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Weight-loss drug reduces sleep apnea severity in late-stage trials
You may also like
Contact Information
- Do not hesitate to contact us if you have questions about the subscription or your ads publish. We are here to help!
- E-mail at [email protected]
- Give us a call at our toll-free number: ((888) 503-2390